About Phil Hall

Phil is an experienced financial journalist responsible for generating original content on the weekly Fairfield County Business Journal and Westchester County Business Journal, plus their respective daily online news sites, podcasts and video interview series.  He is the winner of 2018, 2019 and 2020 Connecticut Press Club Awards and 2019 and 2020 Connecticut Society of Professional Journalists Award for editorial output. Previously, Phil was a United Nations-based reporter for Fairchild Broadcast News, a real estate finance magazine editor, the author of nine books, the  co-host of the award-winning syndicated radio talk show "Nutmeg Chatter." His writing has been featured in The New York Times, New York Daily News, Hartford Courant, Wired, Housing Wire, The Hill's Congress Blog and Profit Confidential. 


Recent Articles By Phil Hall

: WOW |  News, Ratings, and Charts

Should Investors Tune into WideOpenWest?

While some cable providers are struggling with cord-cutting, others are expanding their offerings to take advantage of the newest trends. One such company is WideOpenWest Inc. (WOW). Will the company's efforts boost its stock price? Read more to find out.
: NBEV |  News, Ratings, and Charts

Should NewAge Inc. Be in Your Portfolio?

Formerly New Age Beverages Corp., NewAge Inc.(NBEV) underwent significant restructuring in the second half of 2020. Its stock has material upside and the expected loosening of regulations surrounding cannabis could be a catalyst.
: MBII |  News, Ratings, and Charts

Marrone Bio Innovations: A Chemical Company to Add to Your Watchlist in 2021

Marrone Bio Innovations(MBII) avoided a delisting threat last spring, but is it reaching its fullest potential?
: HIBS |  News, Ratings, and Charts

3 Stocks to Own as Regional Banks Rebound

Regional bank stocks Hingham Institution for Savings (HIFS), Webster Financial (WBS), and German American Bancorp (GABC) don’t get much attention, but they should. Here’s why.
: ARNA |  News, Ratings, and Charts

Is Arena Pharmaceuticals Stock a Good Buy?

After a steep drop in November, Arena Pharmaceuticals (ARNA) is optimistic about 2021, due to its upcoming clinical trials.
: CASY |  News, Ratings, and Charts

Casey’s General Stores Stock Looks Attractive

Midwest retailer Casey’s General Stores (CASY) generated impressive Q2 profits and is a stock to watch in 2021.
: ZYNE |  News, Ratings, and Charts

Should CBD-Focused Zynerba Pharmaceuticals Be In Your Portfolio?

Zynerba Pharmaceuticals (ZYNE) continues to struggle after unsuccessful 2019 clinical trials.
: CXW |  News, Ratings, and Charts

CoreCivic vs. GEO Group: Private Prison Stocks Outlook for 2021

CoreCivic (CXW) prepares to exit the REIT structure, while GEO Group (GEO) stays the course.
: HDB |  News, Ratings, and Charts

Should HDFC Bank Be In Your Stock Portfolio?

Little known to American consumers, HDFC Bank Ltd. (HDB) is a favorite stock of hedge funds and institutional investors.
: YCBD |  News, Ratings, and Charts

What's Happening with cbdMD Stock?

As the CBD market continues to expand, is now a good time to buy shares of cbdMD (YCBD)?

Page generated in 1.2632 seconds.